Current Management Strategy of Nasopharyngeal Carcinoma
نویسندگان
چکیده
منابع مشابه
Current Management Strategy of Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma is an unique head and neck cancer. It is common among the southern Chinese and is closely associated with the Epstein Barr virus (EBV). To diagnose the disease in its early stage is infrequent as the symptoms are usually trivial and patients only present in late stages. Testing the blood for elevated EBV DNA has now become a screening test for the high risk group of pat...
متن کاملCurrent understanding and management of nasopharyngeal carcinoma.
Nasopharyngeal carcinoma (NPC) is a kind of rare head and neck cancer in Japan. However, NPC has some unique features. It is one of the most popular cancers in southern China, Southeast Asia, the Arctic, and the middle East/north Africa. This distinctive racial, ethnical, and geographic predisposition to NPC implies that both genetic susceptibility and environmental factors contribute to the de...
متن کاملNasopharyngeal carcinoma: A review of current updates
Nasopharyngeal carcinoma (NPC) is a rare malignancy worldwide, but it is endemic in a few areas including Southern China, Southeast Asia, North Africa and the Arctic. The underlying mechanisms behind this remarkable geographic distribution remain unclear. Although Epstein-Barr virus (EBV) infection has been suggested as a necessary cause of undifferentiated NPC, EBV itself is not sufficient to ...
متن کاملSurgical management of recurrent nasopharyngeal carcinoma.
OBJECTIVES Nasopharyngeal carcinoma is a unique tumour which is endemic in Southern China including Hong Kong. While the treatment results for primary cancer has been encouraging, management of persistent or recurrent tumours has been challenging. Compared to other surgical approaches, the maxillary swing operation provides spacious access to the bilateral nasopharynx and the ipsilateral paraph...
متن کاملUlcerative Colitis: Current Management Strategy
The primary goals of therapy in the treatment of ulcerative colitis (UC) are to induce remission of patient symptoms as rapidly as possible and maintain remission on a long-term basis. New formulations of mesalazine and corticosteroids show promise in improving compliance and efficacy. There is consistent evidence for the role of cyclosporine in severe UC and expanding evidence for thiopurines ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical and Experimental Otorhinolaryngology
سال: 2010
ISSN: 1976-8710
DOI: 10.3342/ceo.2010.3.1.1